Suscribirse

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study - 20/02/14

Doi : 10.1016/j.amjmed.2013.10.027 
Ido Weinberg a, Philimon Gona b, c, Christopher J. O'Donnell a, b, d, Michael R. Jaff a, 1, , Joanne M. Murabito b, e, 1
a Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, Boston, Mass 
b National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Mass 
c Division of Biostatistics and Health Services Research, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass 
d NHLBI Division of Intramural Research, Bethesda, Md 
e Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Mass 

Requests for reprints should be addressed to Michael R. Jaff, DO, Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, 55 Fruit St., Warren 905, Boston, MA 02114.

Abstract

Background

An increased interarm systolic blood pressure difference is an easily determined physical examination finding. The relationship between interarm systolic blood pressure difference and risk of future cardiovascular disease is uncertain. We described the prevalence and risk factor correlates of interarm systolic blood pressure difference in the Framingham Heart Study (FHS) original and offspring cohorts and examined the association between interarm systolic blood pressure difference and incident cardiovascular disease and all-cause mortality.

Methods

An increased interarm systolic blood pressure difference was defined as ≥10 mm Hg using the average of initial and repeat blood pressure measurements obtained in both arms. Participants were followed through 2010 for incident cardiovascular disease events. Multivariable Cox proportional hazards regression analyses were performed to investigate the effect of interarm systolic blood pressure difference on incident cardiovascular disease.

Results

We examined 3390 (56.3% female) participants aged 40 years and older, free of cardiovascular disease at baseline, mean age of 61.1 years, who attended a FHS examination between 1991 and 1994 (original cohort) and from 1995 to 1998 (offspring cohort). The mean absolute interarm systolic blood pressure difference was 4.6 mm Hg (range 0-78). Increased interarm systolic blood pressure difference was present in 317 (9.4%) participants. The median follow-up time was 13.3 years, during which time 598 participants (17.6%) experienced a first cardiovascular event, including 83 (26.2%) participants with interarm systolic blood pressure difference ≥10 mm Hg. Compared with those with normal interarm systolic blood pressure difference, participants with an elevated interarm systolic blood pressure difference were older (63.0 years vs 60.9 years), had a greater prevalence of diabetes mellitus (13.3% vs 7.5%,), higher systolic blood pressure (136.3 mm Hg vs 129.3 mm Hg), and a higher total cholesterol level (212.1 mg/dL vs 206.5 mg/dL). Interarm systolic blood pressure difference was associated with a significantly increased hazard of incident cardiovascular events in the multivariable adjusted model (hazard ratio 1.38; 95% CI, 1.09-1.75). For each 1-SD-unit increase in absolute interarm systolic blood pressure difference, the hazard ratio for incident cardiovascular events was 1.07 (95% CI, 1.00-1.14) in the fully adjusted model. There was no such association with mortality (hazard ratio 1.02; 95% CI 0.76-1.38).

Conclusions

In this community-based cohort, an interarm systolic blood pressure difference is common and associated with a significant increased risk for future cardiovascular events, even when the absolute difference in arm systolic blood pressure is modest. These findings support research to expand clinical use of this simple measurement.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiovascular disease, Cardiovascular risk, Interarm blood pressure difference


Esquema


 Funding: The Framingham Heart Study is supported by the National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study (contract N01-HC-25195). Analysis for this project was supported by the NHLBI Division of Intramural Research.
 Conflicts of Interest: JMM is a board member of Vascular Interventional Advances (VIVA) Physicians, a 501c3 nonprofit education and research organization; all other authors have no potential conflicts of interest to disclose.
 Authorship: All authors had access to the data; other author roles were as follows: IW, study design, literature search, data interpretation, writing; PG, study design, data analysis, writing; CJD, study design, data interpretation, editing; MRJ, study design, data interpretation, editing; JMM, study design, data interpretation, editing.


© 2014  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 127 - N° 3

P. 209-215 - mars 2014 Regresar al número
Artículo precedente Artículo precedente
  • Too Much Exercise: Right Ventricular Outflow Tract Tachycardia
  • Venkataramanan Gangadharan, Dinesh Sharma, Vijay Ramu, Timir Paul
| Artículo siguiente Artículo siguiente
  • Electronic Health Record Use, Intensity of Hospital Care, and Patient Outcomes
  • Saul Blecker, Keith Goldfeld, Naeun Park, Daniel Shine, Jonathan S. Austrian, R. Scott Braithwaite, Martha J. Radford, Marc N. Gourevitch

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.